(ABBV) AbbVie - Performance 9.2% in 12m
Compare ABBV with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
87.69%
#3 in Group
Rel. Strength
65.64%
#2746 in Universe
Total Return 12m
9.15%
#41 in Group
Total Return 5y
152.80%
#17 in Group
P/E 75.1
90th Percentile in Group
P/E Forward 14.6
56th Percentile in Group
PEG 0.38
74th Percentile in Group
FCF Yield 4.70%
98th Percentile in Group
12m Total Return: ABBV (9.2%) vs XBI (-10.2%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| ABBV NYSE AbbVie |
-18.6% | 9.15% | 153% | 75.1 | 14.6 | 0.38 | -49.6% | -19% |
| UTHR NASDAQ United Therapeutics |
-11.8% | 21% | 168% | 11.8 | 10.6 | 1.43 | 83.8% | 78.5% |
| HLN NYSE Haleon |
-0.87% | 26.7% | 40.5% | 24.7 | 20.3 | 1.8 | 27.1% | - |
| AMGN NASDAQ Amgen |
-12.6% | 8.21% | 36.7% | 38.4 | 14.1 | 0.99 | -18.8% | -20% |
| LONN SW Lonza |
-3.71% | 4.01% | 31% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
| BIM PA Biomerieux |
-1.04% | 14.6% | 7.58% | 31.5 | 25.4 | 1.47 | -58.7% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
-9.08% | -23.9% | -0.25% | 29.1 | 20.7 | 0.27 | 61.5% | 31.6% |
| KMDA NASDAQ Kamada |
-4.41% | 31.6% | -2.82% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
Performance Comparison: ABBV vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ABBV
| Total Return (including Dividends) | ABBV | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -18.60% | -13.99% | -6.90% |
| 3 Months | 1.77% | -13.68% | -11.64% |
| 12 Months | 9.15% | -10.17% | 6.50% |
| 5 Years | 152.80% | -19.71% | 101.06% |
| Trend Score (consistency of price movement) | ABBV | XBI | S&P 500 |
| 1 Month | -88.2% | -80.4% | -74.5% |
| 3 Months | 26.8% | -89.8% | -88.2% |
| 12 Months | 63.5% | -26.1% | 66.1% |
| 5 Years | 94.8% | -52.8% | 84.3% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #115 | -5.35% | -12.6% |
| 3 Month | #24 | 17.9% | 15.2% |
| 12 Month | #41 | 21.5% | 2.49% |
| 5 Years | #16 | 215% | 25.7% |
FAQs
Does ABBV AbbVie outperforms the market?
Yes,
over the last 12 months ABBV made 9.15%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.17%.
Over the last 3 months ABBV made 1.77%, while XBI made -13.68%.
Over the last 3 months ABBV made 1.77%, while XBI made -13.68%.
Performance Comparison ABBV vs Indeces and Sectors
ABBV vs. Indices ABBV is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -0.13% | -11.7% | 2.49% | 2.65% |
| US NASDAQ 100 | QQQ | 0.69% | -10.7% | 2.78% | 4.22% |
| US Dow Jones Industrial 30 | DIA | 1.26% | -12.2% | 2.22% | 3.73% |
| German DAX 40 | DAX | -2.93% | -10.1% | -14.6% | -9.42% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -0.89% | -10.6% | -4.40% | 3.13% |
| Hongkong Hang Seng | HSI | -3.97% | -7.94% | -0.96% | -7.79% |
| India NIFTY 50 | INDA | -3.22% | -24.3% | 0.03% | 5.88% |
| Brasil Bovespa | EWZ | -4.04% | -14.0% | 0.52% | 18.8% |
ABBV vs. Sectors ABBV is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 0.54% | -11.6% | -6.71% | -4.94% |
| Consumer Discretionary | XLY | 1.55% | -13.0% | -0.27% | 0.61% |
| Consumer Staples | XLP | -2.96% | -20.6% | -7.60% | -5.32% |
| Energy | XLE | -5.65% | -8.67% | 2.08% | 19.7% |
| Financial | XLF | -1.39% | -14.0% | -5.30% | -10.2% |
| Health Care | XLV | -0.22% | -11.3% | 3.80% | 9.70% |
| Industrial | XLI | -1.25% | -13.1% | 2.49% | 4.15% |
| Materials | XLB | -3.07% | -11.8% | 9.59% | 16.7% |
| Real Estate | XLRE | -5.17% | -15.1% | 0.85% | -7.99% |
| Technology | XLK | 1.0% | -8.28% | 9.36% | 11.5% |
| Utilities | XLU | -2.92% | -17.5% | -3.46% | -15.9% |
| Aerospace & Defense | XAR | -2.12% | -18.0% | -6.98% | -15.0% |
| Biotech | XBI | -5.81% | -4.61% | 17.0% | 19.3% |
| Homebuilder | XHB | -0.34% | -11.2% | 20.1% | 18.3% |
| Retail | XRT | -0.43% | -15.1% | 7.63% | 13.5% |